Ligand validation:4BDO

KAI: 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE

KAI is a Ligand Of Interest in 4BDO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4BDO_KAI_C_900	74%	12%	0.135	0.966	1.77	2.33	2	5	3	0	100%	1
4BDO_KAI_A_900	74%	11%	0.149	0.98	1.77	2.35	2	6	0	0	100%	1
4BDO_KAI_B_900	67%	12%	0.155	0.964	1.77	2.33	2	5	2	0	100%	1
4BDO_KAI_D_900	53%	12%	0.194	0.957	1.75	2.32	2	5	3	0	100%	0.61
4BDM_KAI_D_900	35%	12%	0.227	0.916	1.51	2.53	1	6	4	0	100%	1
3C33_KAI_B_401	97%	13%	0.067	0.981	2.05	1.88	3	2	0	0	100%	1
4BDR_KAI_B_900	96%	17%	0.063	0.969	1.68	1.94	2	7	1	0	100%	1
3C36_KAI_B_401	95%	15%	0.077	0.982	1.79	1.96	2	4	0	0	100%	1
2XXV_KAI_B_900	95%	17%	0.073	0.976	1.61	2.02	1	5	0	0	100%	1
5MFQ_KAI_B_901	93%	33%	0.084	0.98	1.31	1.35	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.